Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunomodulatory Effects of Stereotactic Body Radiotherapy and Vaccination with Heat-Killed Mycobacterium Obuense (IMM-101) in Patients with Locally Advanced Pancreatic Cancer.
van 't Land FR, Lau SP, de Koning W, Klaase L, Vink M, van Krimpen A, Dumas J, Vadgama D, Nuyttens JJ, Mustafa DAM, Stadhouders R, Willemsen M, Stubbs AP, Aerts JG, van Eijck CHJ. van 't Land FR, et al. Cancers (Basel). 2022 Oct 27;14(21):5299. doi: 10.3390/cancers14215299. Cancers (Basel). 2022. PMID: 36358718 Free PMC article.
Safety and tumour-specific immunological responses of combined dendritic cell vaccination and anti-CD40 agonistic antibody treatment for patients with metastatic pancreatic cancer: protocol for a phase I, open-label, single-arm, dose-escalation study (REACtiVe-2 trial).
Lau SP, van 't Land FR, van der Burg SH, Homs MYV, Lolkema MP, Aerts JGJV, van Eijck CHJ. Lau SP, et al. Among authors: van t land fr. BMJ Open. 2022 Jun 16;12(6):e060431. doi: 10.1136/bmjopen-2021-060431. BMJ Open. 2022. PMID: 35710239 Free PMC article.
Feasibility, safety, and efficacy of stereotactic body radiotherapy combined with intradermal heat-killed mycobacterium obuense (IMM-101) vaccination for non-progressive locally advanced pancreatic cancer, after induction chemotherapy with (modified)FOLFIRINOX - The LAPC-2 trial.
van 't Land FR, Latifi D, Moskie M, Homs MYV, Bosscha K, Bonsing BA, Mieog SD, van der Harst E, Coene PLO, Wijsman JH, van der Schelling GP, Groot Koerkamp B, Nuyttens JJ, van Eijck CHJ; South West Pancreatic Cancer Care SWPCC consortium. van 't Land FR, et al. Radiother Oncol. 2023 Jun;183:109541. doi: 10.1016/j.radonc.2023.109541. Epub 2023 Feb 20. Radiother Oncol. 2023. PMID: 36813171 Clinical Trial.
Increasing Systemic Immune-inflammation Index During Treatment in Patients With Advanced Pancreatic Cancer is Associated With Poor Survival: A Retrospective, Multicenter, Cohort Study.
van 't Land FR, Aziz MH, Michiels N, Mieog JSD, Bonsing BA, Luelmo SAC, Homs MYV, Groot Koerkamp B, Papageorgiou G, van Eijck CHJ. van 't Land FR, et al. Ann Surg. 2023 Dec 1;278(6):1018-1023. doi: 10.1097/SLA.0000000000005865. Epub 2023 Apr 3. Ann Surg. 2023. PMID: 37010512 Free PMC article.
Nationwide Use and Outcome of Surgery for Locally Advanced Pancreatic Cancer Following Induction Chemotherapy.
Stoop TF, Seelen LWF, van 't Land FR, Lutchman KRD, van Dieren S, Lips DJ, van der Harst E, Kazemier G, Patijn GA, de Hingh IH, Wijsman JH, Erdmann JI, Festen S, Groot Koerkamp B, Mieog JSD, den Dulk M, Stommel MWJ, Busch OR, de Wilde RF, de Meijer VE, Te Riele W, Molenaar IQ, van Eijck CHJ, van Santvoort HC, Besselink MG; Dutch Pancreatic Cancer Group. Stoop TF, et al. Among authors: van t land fr. Ann Surg Oncol. 2024 Apr;31(4):2640-2653. doi: 10.1245/s10434-023-14650-6. Epub 2023 Dec 17. Ann Surg Oncol. 2024. PMID: 38105377
ASO Author Reflections: Nationwide Experience on Locally Advanced Pancreatic Cancer Surgery After Induction Chemotherapy in the Netherlands: A Stepping Stone for the PREOPANC-4 Trial.
Stoop TF, Seelen LWF, van 't Land FR, van Eijck CHJ, van Santvoort HC, Besselink MG; Dutch Pancreatic Cancer Group. Stoop TF, et al. Among authors: van t land fr. Ann Surg Oncol. 2024 Apr;31(4):2658-2659. doi: 10.1245/s10434-023-14704-9. Epub 2023 Dec 13. Ann Surg Oncol. 2024. PMID: 38093164 No abstract available.